Record Display for the EPA National Library Catalog


Main Title A Review of the Scientific Literature As It Pertains to Gulf War Illnesses.
Other Authors
Author Title of a Work
Golomb, Beatrice Alexandra.
Marshall, Grant N.
Harley, Naomi H.
Spektor, Dalia M.
Cecchine, Gary.
Hilborne, Lee H.
Publisher Rand,
Year Published 1998
OCLC Number 40113369
ISBN 0585302367; 9780585302362; 0833026763; 9780833026767; 0833026771; 9780833026774; 0833026798; 0833026801; 9780833026804; 0833026682; 083302681X; 0833026828; 0833026836; 9780833026835; 0833027956; 9780833027955; 9780833026798; 9780833026682; 9780833026811; 9780833026828
Subjects Persian Gulf syndrome ; BUSINESS & ECONOMICS--Human Resources & Personnel Management ; MEDICAL--Health Policy
Internet Access
Description Access URL
EBSCOhost, Vol. 1 (netLibrary)
EBSCOhost, Vol. 2 (netLibrary)
EBSCOhost, Vol. 4 (netLibrary)
EBSCOhost, Vol. 5 (netLibrary)
Exec. summary of vol. 2
Exec. summary of vol. 2
Vol. 1
Vol. 2
Vol. 4
Vol. 5
Vol. 6
Vol. 7
Vol. 8
Vol. 2
The Edward Potts Cheyney Memorial Fund Home Page
Library Call Number Additional Info Location Last
EJEM  RB152.7.R48 v.8 2000 OCSPP Chemical Library/Washington,DC 01/02/2004
Collation volumes <1-2, 4-8> : illustrations, maps ; 26 cm.
"Prepared for the Office of the Secretary of Defense, National Defense Research Institute." "MR-1018-OSD." Includes bibliographical references.
Contents Notes
The confrontation that began when Iraq invaded Kuwait in August 1990 brought with it the threat that chemical and biological weapons might be used against the more than half a million military personnel the United States deployed to the region. To protect these troops from such threats, the Department of Defense wished to use drugs and vaccines that, not having been tested for use in these specific situations, were considered "investigational" by the federal Food and Drug Administration. This report examines the history of the Interim Rule, adopted in December 21, 1990, that authorized the Commissioner of Food and Drugs to waive informed consent for the use of investigational drugs and vaccines for certain military uses; how this authority was used for pyridostigmine bromide and botulinum toxoid during the Gulf War; and the subsequent controversy surrounding the rule, its application, and its implications.